An Examination of the Antibacterial, Antifungal, Anti-Giardial and Anticancer Properties of Buchanania obovata Engl. Fruit Extracts

groupview

Abstract
Pharmacognosy Communications,2019,9,1,07-14.
Published:January 2019
Type:Original Article

An Examination of the Antibacterial, Antifungal, Anti-Giardial and Anticancer Properties of Buchanania obovata Engl. Fruit Extracts

Cécile Mazerand1,2, Ian Edwin Cock1,3*

1School of Environment and Science, Griffith University, Brisbane, 4111, AUSTRALIA.

2School of Biology, Ecole de Biologie Industrielle (EBI), Cergy, FRANCE.

3Environmental Futures Research Institute, Griffith University, Brisbane, AUSTRALIA.

Abstract:

Background: Buchanania obovata is an endemic Australian plant that has been used traditionally to treat a variety of bacterial, fungal and protozoal pathogenic diseases. This study was undertaken to test B. obovata fruit extracts for the ability to inhibit microbial and cancer cell growth. Materials and Methods: B. obovata fruit powder was extracted and tested for antimicrobial activity using disc diffusion and MIC methods. Inhibitory activity against the gastrointestinal protozoal parasite Giardia duodenalis and antiproliferative activity against human colorectal (Caco2) and cervical (HeLa) cancer cell lines was evaluated using MTS-based colorimetric assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay. Results: The methanol, water and ethyl acetate B. obovata fruit extracts displayed potent antibacterial activity. The methanol and water extracts displayed the broadest specificity, inhibiting the growth of all of the Gram positive and Gram negative bacterial species tested. The ethyl acetate extract also displayed antibacterial activity, inhibiting the growth of 7 (88%) of the Gram negative and 2 (50%) of the Gram positive bacterial species. The methanol extract also displayed broad spectrum antifungal activity, inhibiting the growth of all 3 fungal species, including an ampicillin resistant strain of A. niger. The water extract also inhibited the growth of 2 (66%) of the fungal species tested. None of the extracts were particularly good inhibitors of the growth of the gastrointestinal parasite Giardia duodenalis. The methanolic and aqueous extracts were effective at blocking the proliferation of the colorectal cancer cell line Caco2 to between approximately 20 and 30% of the untreated cell growth. All extracts also inhibited HeLa cervical cancer cell growth. The methanol, water and ethyl acetate extracts displayed substantial toxicity in the Artemia nauplii assay. Conclusion: This study shows that B. obovata fruit extracts inhibit bacteria and fungi, but are relatively ineffective against G. duodenalis. The extracts were also effective inhibitors of Caco2 and HeLa cell proliferation, indicating that the extracts have potential in the treatment of microbial diseases and some cancers.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.